Katy as at 26 Sep 18 in ann report instos - first 8 shareholders - own 58% of the stock. I think all of them will be on-side from a risk spreading perspective. We should all vote NO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025